Get the Stockscreener App
20.02
4.87%
0.93
Braveheart Bio, Inc. Common Stock Stock (BRVE) Forecast
The Braveheart Bio, Inc. Common Stock (BRVE) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $18.54, representing a -7.39% decrease from the current price of $20.02. The highest analyst price target is $21.65, and the lowest is $15.43.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BRVE Price Target
Average 11.27
(-43.69% Downside)
Is Braveheart Bio, Inc. Common Stock (BRVE) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 39.09 | Neutral |
| STOCH(9,6) | 23.44 | Neutral |
| STOCHRSI(14) | 91.25 | Sell |
| MACD(12,26) | -1.9278 | Sell |
| ADX(14) | 35.88 | Sell |
| William %R | -71.39 | Neutral |
| CCI(14) | -30.78 | Neutral |
Buy: 0
Sell: 3
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
20.51
Sell
|
20.66
Sell
|
| MA20 |
22.86
Sell
|
22.25
Sell
|
| MA50 |
23.39
Sell
|
0.00
Buy
|
| MA100 |
11.69
Buy
|
0.00
Buy
|
| MA200 |
5.8466
Buy
|
0.00
Buy
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, BRVE could be considered a Moderate Sell, with 17 technical analysis indicators signaling 5 Buy signals, 8 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on BRVE, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 39.09 indicates that BRVE is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 23.44 indicates that BRVE is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 91.25 indicates that BRVE is oversold. This suggests that BRVE price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 35.88 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -30.78 indicates that BRVE is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term BRVE price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Braveheart Bio, Inc. Common Stock financial reports and earnings history, Braveheart Bio, Inc. Common Stock (BRVE) stock could reach $113.55 by 2030, $452.59 by 2040 and $985.96 by 2050. See the projected annual prices until 2050 of the Braveheart Bio, Inc. Common Stock stock below:
- Braveheart Bio, Inc. Common Stock (BRVE) is expected to reach an average price of $331.99 in 2035, with a high prediction of $337.26 and a low estimate of $231.86. This indicates an $1,558% rise from the last recorded price of $20.02.
- Braveheart Bio, Inc. Common Stock (BRVE) stock is projected to chart a bullish course in 2040, with an average price target of $397.10, representing an $1,884% surge from its current level. The forecast ranges from a conservative $398.49 to a sky-high $452.59.
- Our analysts predict Braveheart Bio, Inc. Common Stock (BRVE) to jump 2,968% by 2045, soaring from $617.25 to an average price of $614.27, potentially reaching $702.75. While $617.25 is the low estimate, the potential upside is significant.
- Braveheart Bio, Inc. Common Stock (BRVE) stock is expected to climb by 2050, reaching an average of $879.58, a $4,294% jump from its current level. However, a wide range of estimates exists, with high and low targets of $985.96 and $880.77, respectively, highlighting the market's uncertainty.
Braveheart Bio, Inc. Common Stock Stock (BRVE) Year by Year Forecast
Braveheart Bio, Inc. Common Stock Stock (BRVE) Price Forecast for 2026
The predicted value for Braveheart Bio, Inc. Common Stock (BRVE) in 2026 is set at an average of $21.46. Estimates vary from a peak of $32.00 to a trough of $10.92, indicating an +7.20% surge from the present price of $20.02.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $21.16 | $15.43 | $21.65 | +5.68% |
| December, 2026 | $13.08 | $10.92 | $21.13 | -34.65% |
Braveheart Bio, Inc. Common Stock Stock (BRVE) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Braveheart Bio, Inc. Common Stock (BRVE) is $14.39, with a high forecast of $27.88 and a low forecast of $0.895. This indicates an -28.13% decrease from the last price of $20.02.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $9.14 | $5.2033 | $12.59 | -54.35% |
| February, 2027 | $13.11 | $6.5583 | $13.41 | -34.50% |
| March, 2027 | $0.06 | $1.475 | $13.37 | -99.70% |
| April, 2027 | $1.12 | $1.2763 | $2.885 | -94.41% |
| May, 2027 | $2.27 | $0.895 | $5.60 | -88.66% |
| June, 2027 | $11.78 | $1.76 | $7.92 | -41.14% |
| July, 2027 | $7.6466 | $9.4916 | $7.5917 | -61.80% |
| August, 2027 | $7.5833 | $5.9533 | $7.45 | -62.12% |
| September, 2027 | $19.55 | $9.8866 | $17.90 | -2.33% |
| October, 2027 | $14.96 | $15.13 | $16.50 | -25.27% |
| November, 2027 | $14.66 | $14.00 | $14.94 | -26.76% |
| December, 2027 | $27.46 | $28.73 | $27.88 | +37.16% |
Braveheart Bio, Inc. Common Stock Stock (BRVE) Price Forecast for 2028
In 2028, Braveheart Bio, Inc. Common Stock (BRVE) is projected to reach an average price of $44.92, with a high projection of $67.80 and a low estimate of $22.04. This indicates an +124.38% rise from the last price of $20.02.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $25.98 | $22.04 | $25.29 | +29.77% |
| February, 2028 | $39.86 | $23.40 | $37.86 | +99.10% |
| March, 2028 | $36.61 | $37.81 | $35.93 | +82.88% |
| April, 2028 | $33.75 | $30.08 | $32.40 | +68.56% |
| May, 2028 | $50.60 | $30.61 | $47.84 | +152.73% |
| June, 2028 | $42.03 | $43.88 | $45.30 | +109.96% |
| July, 2028 | $36.44 | $37.83 | $37.41 | +82.00% |
| August, 2028 | $57.26 | $37.63 | $57.82 | +186.01% |
| September, 2028 | $48.24 | $48.41 | $53.10 | +140.96% |
| October, 2028 | $42.41 | $44.57 | $44.90 | +111.84% |
| November, 2028 | $64.06 | $65.33 | $67.80 | +219.98% |
| December, 2028 | $51.23 | $54.21 | $60.78 | +155.91% |
Braveheart Bio, Inc. Common Stock Stock (BRVE) Price Forecast for 2029
The 2029 price forecast for Braveheart Bio, Inc. Common Stock Stock (BRVE) is $84.60 on average, with a high prediction of $117.70 and a low estimate of $51.51. This represents an +322.59% increase from the previous price of $20.02.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $79.78 | $51.51 | $77.78 | +298.50% |
| February, 2029 | $72.11 | $73.30 | $74.74 | +260.17% |
| March, 2029 | $64.81 | $62.26 | $66.78 | +223.74% |
| April, 2029 | $89.41 | $58.44 | $87.76 | +346.60% |
| May, 2029 | $76.42 | $78.26 | $83.00 | +281.72% |
| June, 2029 | $69.68 | $69.87 | $69.87 | +248.05% |
| July, 2029 | $94.97 | $65.38 | $97.74 | +374.36% |
| August, 2029 | $81.52 | $81.69 | $89.70 | +307.19% |
| September, 2029 | $72.50 | $73.89 | $75.06 | +262.15% |
| October, 2029 | $100.66 | $72.32 | $107.72 | +402.80% |
| November, 2029 | $83.41 | $86.39 | $96.28 | +316.62% |
| December, 2029 | $119.70 | $79.25 | $117.70 | +497.90% |
Braveheart Bio, Inc. Common Stock Stock (BRVE) Price Forecast for 2030
Braveheart Bio, Inc. Common Stock Stock (BRVE) is expected to reach an average price of $121.90 in 2030, with a high forecast of $157.62 and a low forecast of $86.19. This signifies an +508.92% surge from the last price of $20.02.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $107.60 | $108.79 | $113.55 | +437.46% |
| February, 2030 | $95.88 | $94.43 | $101.17 | +378.92% |
| March, 2030 | $129.68 | $86.19 | $127.68 | +547.75% |
| April, 2030 | $110.81 | $112.65 | $123.26 | +453.48% |
| May, 2030 | $99.64 | $99.83 | $103.15 | +397.70% |
| June, 2030 | $137.93 | $93.13 | $137.66 | +588.94% |
| July, 2030 | $114.80 | $114.97 | $130.14 | +473.43% |
| August, 2030 | $101.36 | $102.75 | $107.24 | +406.28% |
| September, 2030 | $137.26 | $100.06 | $147.64 | +585.61% |
| October, 2030 | $115.58 | $118.56 | $131.77 | +477.32% |
| November, 2030 | $104.84 | $107.00 | $112.31 | +423.68% |
| December, 2030 | $143.09 | $144.29 | $157.62 | +614.75% |
0.41%
3.98%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):